S. 3751 · Senate bill · 119th Congress
Prescription Drug Supply Chain Pricing Transparency Act Introduced Jan 29, 2026 In committee Jan 29, 2026 Finance Passed the Senate (not yet) Passed the House (not yet) Law (not yet) What it would change (1) About this text
1 section of the Code · 1 change asked for
Text: introduced in Senate Introduced The text as a member of Congress first filed it. Most bills never get further than this. , Jan 29, 2026 (the only version so far)
Official text on Congress.gov
Written by AIWhat this bill would change in the Code
This change would add a new subsection (e) at the end of this section of the Medicare Part D law. It would direct the Comptroller General, who heads the Government Accountability Office, to study fees and payments tied to a drug's price in the retail prescription drug supply chain, such as fees set as a percentage of the drug's price. The study would cover pharmacy benefit managers, Part D plan sponsors, wholesalers, pharmacies, manufacturers, and advisers. It would look at business models, conflicts of interest, and trends. A report with recommendations would be due to Congress within 2 years of enactment.
This is the note on the one section the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
42 U.S.C. Chapter 7 · Social Security 1 section